InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-10.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Quay Steven C, 首席执行官. Insider active across 2 companies, notably Atossa Therapeutics, INC.. Cumulatively, 5 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €9k. History available since 21 May 2025. The latest transaction was filed on 27 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Quay Steven C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
65,000 股0Common StockSEC:0001193125-26-134861:0
331,674 股0Common StockSEC:0001193125-26-030571:0
325,203 股0Common StockSEC:0001193125-26-019273:0
11,239 股@ US$0.8797100.0% 占其流量Common StockSEC:0000950170-25-076523:0
标准退出：2025年8月19日 (T+90)
50,000 股Common StockSEC:0001144204-16-076463:0
标准退出：2016年4月18日 (T+90)
5 条申报中的 5 条
About Quay Steven C
Steven C. Quay is the President and Chief Executive Officer at Atossa Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing operations. His leadership is essential for the growth and success of Atossa.
